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In radiotherapy often new ideas are implemented in clinical practice 
without preclinical research on animal models. On the other hand, in 
radiobiology often animal models are employed but commonly 
irradiations are imprecise, using setups that bear little resemblance to 
clinical state-of-the-art. Recently a new field of research in 
radiotherapy was born; image-guided precision radiotherapy. Many 
now believe that by performing precise irradiation of small structures 
in animal models much may be learned in terms of radiation response 
of normal and cancerous tissues. New knowledge may be gained on 
the efficacy of complex spatial and temporal radiation patterns, the 
synergy of radiation with drugs (not restricted to chemotherapy), the 
influence of organ motion, and much more. It is hoped that this 
knowledge could then be translated to cancer patients.  
Precision irradiation of small structures in animals such as mice and 
rats requires special measures to safeguard correct radiation delivery. 
The new field of research poses many stringent technological 
demands. The radiation beams are very small, down to sub-millimeter 
dimensions, with sub-millimeter placement precision. To prevent 
excessive buildup and penumbra effects, energy of the beams is in the 
kilovolt rather than megavolt region. This downscaling in energy and 
beam size poses high demands on the hardware control systems and 
treatment planning software. To ensure correct beam delivery, high-
resolution image-guidance of the irradiation procedure, from the 
planning stage to the delivery stage, is paramount.  
Recently, several image-guided precision irradiation research 
platforms for small animals became available. Commissioning and 
operation of this new technology requires special procedures to 
enable precise and accurate treatments. Examples include highly 
accurate mechanical alignment of radiation beams, compensation for 
beam sagging, the use of high-resolution film dosimetry and dedicated 
phantoms. Attention has also been devoted to establishing optimal 
workflows for high-throughput studies. Since radiation treatment 
planning systems for cancer patients are not suitable for the small 
beams, small animal voxel sizes and low photon energies of the 
employed beams, dedicated dose calculation software has been 
developed.  
In this presentation the novel image-guided precision irradiation 
technology will be discussed. Its potential to elucidate radiation 
interaction mechanisms in biological targets and to advance 
radiotherapy practice will also be discussed with some examples.  
   
SP-0515   
Multi-modal preclinical imaging: challenges and opportunities in 
cancer discovery and treatment 
C. Kuntner1, T. Wanek1, O. Langer1 
1AIT Austrian Institute of Technology GmbH, Health & Environment 
Department, Seibersdorf, Austria  
 
Multi-modal imaging is an emerging field in both clinical diagnostics 
and basic research as it allows monitoring of functional processes and 
additionally delivers anatomical information. Over the past decade, 
we have observed an increasing demand for such imaging techniques 
for different biological and medical applications. Similar to human 
imaging, small-animal imaging modalities were proposed to combine 
nuclear medicine techniques such as positron emission tomography 
(PET) and single photon emission computed tomography (SPECT) with 
computed tomography (CT) or magnetic resonance imaging (MRI). 
Although the most clinically applied multi-modality system is PET/CT, 
in preclinical research this combination suffers from some limitations 
which are mainly related to the applied radiation dose and the limited 
soft tissue contrast as well as the sequential scans rather than 
simultaneous scans, which could provide information for motion 
correction. In contrast to PET/CT an integrated PET/MRI scanner 
could provide simultaneous data acquisition for temporal and spatial 
image fusion. This talk will review several options for multi-modal 
imaging and results from small-animal studies will be presented.   
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Dynamic radiation Therapy employs deformable image registration 
(DIR) as a method for automatic contour propagation of regions of 
interest (ROI) and deformable dose accumulation (DDA). The goal of 
DDA is firstly to determine if the treatment is being delivered as 
planned, by acquiring additional image sets through out the course of 
treatment (in addition to the planning image) and secondly, to adjust 
the treatment plan if objectives are not being met as intended. In this 
lecture we describe errors that potentially impact on DDA and a 
method that can be used to minimize their impact on the resulting 
accumulated dose distribution. Even though, DIR and DDA do hold 
great clinical promise for improved prediction of expected normal 
tissue toxicities and have the potential to allow one to escalate the 
dose to target structures at constant expected normal tissue toxicity 
probability (NTCP), i.e. allowing one to pursue an iso-NTCP escalation 
strategies. Their potential clinical use, however, should be explored 
carefully in prospective clinical trials.  
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In order to accumulate dose between two treatments or treatment 
fractions, the underlying anatomy of the patient should be aligned. 
Due to the changes in the anatomy, such as deformations and motion, 
non-rigid registration is required. Therefore, dose mapping/ 
accumulation is directly influenced by the uncertainties of the non-
rigid registration method that is used. Uncertainties related to the 
non-rigid registration include, among others, the consistency or 
transitivity, low contrast on the input images for intensity-based 
registrations, and distance to features for feature-based registration. 
 When registrations are inconsistent or non-transitive, the resulting 
cumulative dose depends on the pathways used to map the dose 
(Bender et al. Med. Phys, 39(1) 2012, Bondar et al. Med. Phys, 37(7) 
2010). Also a large uncertainty in the cumulated dose is generated 
when images with few visible features are used for the registration, 
since the registration may not map correctly the homogeneous areas 
(Zhong et al. Med. Phys, 37(3) 2010, Salguero et al. Med. Phys, 38(1) 
2011). It also has been shown that the registration error is related to 
the distance to the features used in the registration; the further 
away, the least reliable is the transformation (Zhong et al. Med. Phys, 
37(3) 2010, Chi et al. Med Phys, 33(2) 2006). Besides uncertainties 
related to the non-rigid registration, dose mapping/accumulation also 
depends on the properties of the dose distribution. For example, large 
variations were found for an organ at risk close to the target volume 
after a perturbation analysis for dose addition between external-beam 
radiotherapy and brachytherapy for head and neck cases (Vásquez 
Osorio et al. IJROBP, 80(4) 2011). The reason for the large variations 
was the extremely steep gradient produced by a brachytherapy 
catheter which was partially included in the organ (constrictor 
muscle), therefore a small perturbation on the mapped location 
resulted in a very large variation on the mapped dose. In conclusion, 
although dose accumulation may give us a better approximation of the 
dose that was 'really' received by the patient, making decisions only 
based on the total dose should be done with care, especially when it 
influences patient treatment. The need for more tools for estimating 
the degree of certainty of the cumulated dose should be developed 
and integrated into the clinical process. 
   
 
 
 
 
